Background: Trends in the prevalence and control of diabetes defined by hemoglobin A 1c (HbA 1c ) levels are important for health care policy and planning.
T
here has been a staggering increase in the prevalence of obesity over the past 30 years in the United States (1, 2) . Diagnosed diabetes has increased concomitantly (3) (4) (5) (6) . In a major change to clinical guidelines in 2010, hemoglobin A 1c (HbA 1c ) was recommended for use as a diagnostic test for diabetes (7) . In addition to its central role in monitoring glycemic control, HbA 1c is now widely used as the first-line test for diagnosis of diabetes (8, 9) . However, use of HbA 1c levels to characterize U.S. trends in prediabetes, undiagnosed diabetes, and glycemic control in NHANES (National Health and Nutrition Examination Survey) has been complicated by the challenges of ensuring a constant calibration of the assay over a long period of time, which included changes in laboratory method (10, 11) . Uncalibrated mean HbA 1c levels have increased over successive NHANES surveys, even in normal-weight persons (12) , but without parallel increases in fasting glucose levels. No specific cause for the shift in HbA 1c levels has been identified (10) . The magnitudes of the changes in the distributions are small (approximately 4% to 5%), and such small shifts potentially would not be detectable in most laboratory quality-control analyses. Although such small changes are not important for individual (clinical) classification, they can have a substantial effect at the population level. They are particularly important when examining trends over time and looking at specific regions of the distribution. These shifts have significant ramifications for estimating the prevalence of diabetes and prediabetes in the population. We addressed these issues by calibrating the HbA 1c values to a stable standard distribution among young, healthy NHANES participants and then used the calibrated values to obtain national estimates.
Our objective was to update national trends in total diabetes (undiagnosed and diagnosed), prediabetes, and glycemic control in persons with diagnosed diabetes over the past 2 decades using data from the 1988 -1994 (NHANES III) and 1999 -2010 (continuous NHANES) survey periods based on calibrated HbA 1c and fasting glucose levels.
METHODS

Setting and Participants
The NHANES surveys are cross-sectional, multistage, stratified, clustered probability samples of the U.S. civilian noninstitutionalized population conducted by the National Center for Health Statistics (NCHS), a branch of the Centers for Disease Control and Prevention. Data are available from the continuous NHANES (data released in 2-year cycles) and NHANES III. The protocols for the conduct of NHANES were approved by the NCHS institutional review board, and informed consent was obtained from all participants.
For this study, we limited our population to 43 439 total persons who attended the clinical examination, were aged 20 years or older, were not missing HbA 1c measurements, and were not pregnant: 15 (1988 -1994 ) and the two 6-year survey periods in the continuous NHANES (1999 -2004 and 2005-2010) . We also generated prevalence estimates for each 2-year survey period in the continuous NHANES (1999 -2000, 2001-2002, 2003-2004, 2005-2006, 2007-2008, and 2009 -2010) .
Measurement of HbA 1c and Plasma Glucose Levels
Hemoglobin A 1c levels were measured in whole blood samples using high-performance liquid chromatography methods performed on instruments certified by the Na- Plasma glucose levels were measured in specimens collected from a subsample of participants who attended a morning fasting session using a hexokinase enzymatic method. In NHANES III and NHANES 1999 -2004, plasma glucose levels were measured at the University of Missouri-Columbia using a Roche Cobas Mira instrument (Roche Diagnostics, Indianapolis, Indiana) (13) . Plasma glucose levels were measured at the University of Minnesota using a Roche/Hitachi 911 instrument (Roche Diagnostics) in 2005-2006 and a Roche Modular P instrument (Roche Diagnostics) in 2007-2010. We applied regression equations recommended by the NCHS to account for changes in methods and align the plasma glucose level measurements across survey periods (14, 15) . We confirmed the stability of the calibrated plasma glucose levels in a young, healthy, fasting subsample (see Supplement 1).
Definitions of Diabetes, Prediabetes, and Glycemic Control
Diagnosed diabetes was defined as a physician diagnosis of diabetes (other than during pregnancy) that was selfreported by the participant. Among persons with diagnosed diabetes, we evaluated trends in glycemic control defined by HbA 1c levels less than 7.0% or less than 8.0%. In persons without a diabetes diagnosis, we evaluated trends in undiagnosed diabetes and prediabetes defined using clinical cut points for HbA 1c levels (Ն6.5% and 5.7% to 6.4%, respectively) (8) . In the fasting subsample, we compared trends in undiagnosed diabetes and prediabetes defined using calibrated HbA 1c levels with those defined using fasting glucose level cut points (Ն7.0 mmol/L [Ն126 mg/dL] and 5.6 to 6.9 mmol/L [100 to 125 mg/ dL], respectively). Also in the fasting subsample, we exam-
Context
Accurate information about the epidemiology of diabetes is important in identifying public health needs and areas on which to focus interventions. Changes in the methods used to measure hemoglobin A 1c (HbA 1c ) may substantially affect population estimates of the burden of diabetes.
Contribution
This study calibrated HbA 1c levels from more than 20 years to allow comparison. Diabetes prevalence in the United States has increased, largely associated with increasing obesity. Although the proportion of undiagnosed diabetes has declined and glycemic control among diagnosed patients has improved overall, disparities in prevalence, undiagnosed disease, and glycemic control persist or have worsened among non-Hispanic blacks and Mexican Americans.
Implication
Despite improvements in glycemic control overall, the prevalence of diabetes is increasing and substantial disparities in diagnosis and care persist.
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Original Research Trends in Prevalence and Control of Diabetes in the United States ined trends in total confirmed cases of diabetes, defined as diagnosed diabetes or both elevated fasting glucose levels (Ն7.0 mmol/L [Ն126 mg/dL]) and HbA 1c levels (Ն6.5%), a definition that more closely approximates cases that would be classified as having diabetes in clinical practice (8) . The term "total diabetes" is used here to refer to the combination of diagnosed and undiagnosed diabetes where undiagnosed cases were defined by either an elevation in fasting glucose levels, an elevation in HbA 1c levels, either, or both (confirmed cases).
Other Measures
Anthropometry measurements, including waist circumference, height, and weight, were measured using a standardized protocol. Body mass index (BMI) was calculated from measured height and weight. We used clinical categories of BMI to define normal weight (Ͻ25 kg/m 2 ), overweight (25 to Ͻ30 kg/m 2 ), and obese (Ն30 kg/m 2 ). High-risk waist circumference was defined as 102 cm or greater in men and 88 cm or greater in women (16) . Information on age and race or ethnicity was self-reported. Diabetes medication use and type (oral hypoglycemic agents or insulin) was self-reported among persons who reported a diagnosis of diabetes.
Statistical Analysis
We used an equipercentile equating approach to statistically correct for the nonequivalency of HbA 1c values across the NHANES surveys (17-19) (see Supplement 2, available at www.annals.org). Prevalence estimates and their SEs were obtained for each survey period. We examined 2-year survey cycles and also combined estimates across 6-year survey periods to provide more reliable estimates, according to NCHS guidelines. Analyses were done incorporating sampling weights to obtain unbiased estimates from the complex NHANES sampling design. We obtained SEs using the Taylor series (linearization) method following analytic procedures recommended by the NCHS levels (20, 21) . Prevalence estimates from this study are nationally representative of the civilian, noninstitutionalized U.S. population of adults aged 20 years or older. Prevalence estimates for 2005-2010 were applied to the 2010 Census population to obtain estimates of the number of persons with diabetes in the United States in 2010. We used logistic regression to obtain predictive margins to examine trends in total diabetes (diagnosed diabetes or calibrated HbA 1c levels Ն6.5%) after adjustment for demographic characteristics, BMI, and waist circumference. P values for linear trend were calculated by regressing the continuous variable of interest (such as BMI) on the median year of the survey cycle. Statistical analyses were conducted using Stata, version 13.0 (StataCorp, College Station, Texas), and R, version 2.15.1 (R Foundation for Statistical Computing, Vienna, Austria). We used svy commands in Stata to account for the complex survey design of NHANES; the prop command to obtain prevalence estimates; and the logistic command in conjunction with the margins, nlcom, and test postestimation commands to obtain predictive margins and prevalence ratios with 95% CIs and P values. The equipercentile equating was conducted using the equate package in R.
Role of the Funding Source
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RESULTS
Demographic characteristics of the U.S. population aged 20 years or older without diagnosed diabetes remained relatively stable across the survey periods, with the exception of changes in the racial or ethnic makeup of the population ( Table 1 ). Most notable, there was a substantial increase in the percentage of persons self-reporting race or ethnicity as Mexican American. The mean BMI of the U.S. adult population increased significantly over this period (P trend Ͻ 0.001), and the prevalence of obesity increased from 21.2% in 1988 -1994 Table 2) .
In general, trends in prevalence of total diabetes, undiagnosed diabetes, prediabetes, and glycemic control were similar when the continuous NHANES (1999 -2010) was divided into 2-year cycles ( Table 2 of Supplement 2).
Despite considerable increases in total diabetes cases over the past 2 decades, trends in undiagnosed diabetes (whether defined by fasting glucose or calibrated HbA 1c levels) have remained fairly stable ( Table 2) . As a result of these trends, the proportion of total diabetes cases that are undiagnosed has decreased. Major differences in the prevalence of diagnosed and undiagnosed diabetes were seen by age and race or ethnic groups (Figure 1 ). There were also substantial differences in type of diabetes treatment and glycemic control by age group (Table 3 of Supplement 2).
There was a substantially greater prevalence of diabetes, notably undiagnosed diabetes, in ethnic minorities compared with whites. This disparity has increased over the past 20 years ( Table 4 of Supplement 2 and Figure 1) . Indeed, the prevalence of total diabetes (diagnosed diabetes Figure 2) . Overall estimates of diabetes cases were slightly lower with this more specific definition, but the trends remained similar to previous analyses. Figure 2 shows the prevalence of total confirmed diabetes juxtaposed with trends in the preva- ). The decrease in undiagnosed diabetes as a proportion of total diabetes cases is also evident from this figure; undiagnosed cases were 16% of total confirmed diabetes cases in 1988 -1994 (0.9% of 5.5%) but only 11% in 2005-2010 (1.0% of 9.3%). When applied to the 2010 U.S. Census, the total number of adults aged 20 years or older with total confirmed diabetes was 20.6 million ( Table 5 of Supplement 2).
Compared with 1988 -1994, the greater prevalence of total diabetes in 1999 -2004 and 2005-2010 remained significant after adjustment for demographic characteristics (Table 3) . However, after further adjustment for current BMI and waist circumference, the prevalence ratios were strongly attenuated (P values were 0.136 and 0.058, respectively), suggesting that changes in demographic characteristics and adiposity explained most of the increase in total diabetes prevalence in the United States.
DISCUSSION
The prevalence of diabetes has increased substantially over the past 2 decades. The prevalence of total confirmed diabetes (diagnosed and undiagnosed) among noninstitutionalized adults aged 20 years or older in the United States was 9.3% in 2005-2010 compared with 7.6% in 1999 -2004 and 5.5% in 1988 -1994. This corresponds to approximately 21 million U.S. adults with total confirmed diabetes in 2010. Despite the increase in total diabetes cases, the prevalence of undiagnosed diabetes has remained fairly stable, which probably reflects improvements in screening and diagnosis. As a result of these trends, the proportion of diabetes cases that are undiagnosed has decreased over the past 20 years. At present, the proportion of persons with undiagnosed diabetes is only 11% of total confirmed diabetes cases. Our analyses used calibrated HbA 1c levels to account for population-wide shifts in the distribution of HbA 1c levels across NHANES cycles that could not be attributed to metabolic processes. However, it is important to note that the observed calibration differences were within the range of error of the HbA 1c assays (Ͻ5%) and would likely not be detected by standard laboratory quality control methods.
We found that the increases in diabetes cases over the past 2 decades were largely explained by increases in obesity. It should be noted that current levels of BMI and waist circumference are unlikely to fully capture the true cumulative effects of adiposity. Thus, the estimates from our regression model cannot fully eliminate residual confounding because of the cross-sectional design, mismeasurement of adiposity, and unmeasured factors that have also contributed to the increase in diabetes in the U.S. population.
We saw striking differences in the prevalence of diabetes by age and race or ethnicity. Recent studies have highlighted the important effect that diabetes can have on functional status and mobility (22) (23) (24) , cognition (25) (26) (27) , fracture risk (28) , and life expectancy (29) . The high burden of diabetes among older adults suggests the need for national efforts to address this growing population, partic- Original Research Trends in Prevalence and Control of Diabetes in the United States ularly as the number of older adults is expected to increase dramatically over the next 2 decades (30). The substantially greater prevalence of diabetes and prediabetes and poor rates of glycemic control (even among persons with medication-treated diabetes) in ethnic minority populations compared with whites is particularly concerning because blacks and Mexican Americans are also at greater risk for complications of diabetes, particularly retinopathy and kidney disease (31) (32) (33) (34) .
The past 2 decades have seen increases in the use of oral diabetes medications and improvements in glycemic control among persons with diagnosed diabetes. In combination with evidence for better detection (smaller proportion of undiagnosed cases), these results are consistent with improvements in diabetes screening and care in the past 20 years. Nonetheless, despite these improvements, large portions of the population are not achieving optimal HbA 1c levels, suggesting that further efforts are needed.
Because fasting glucose and HbA 1c levels are often used in combination or would be repeated in clinical practice to confirm a diagnosis (8), we included a definition of diabetes where elevated fasting glucose levels were "confirmed" with elevated HbA 1c levels. This results in a more conservative estimate of the prevalence of diabetes in the population, especially compared with definitions that use a single fasting glucose level measurement, which has high within-person variability (35) . Consistent with other studies, we found that the prevalence of prediabetes based on fasting glucose levels (5.6 to 6.9 mmol/L [100 to 125 mg/ dL]) was more than double the prevalence defined by cal- (37) (38) (39) (40) . Of importance, after calibration, the trends in undiagnosed diabetes and prediabetes based on HbA 1c levels were more closely aligned to those based on fasting glucose levels. Several limitations of this study deserve mention. First, this analysis was based on cross-sectional data, and we cannot determine the causes for the underlying trends. Second, we relied on single measurements of fasting glucose and HbA 1c levels to identify undiagnosed cases of diabetes; in clinical practice, these measurements should be repeated to confirm the diagnosis. Third, we relied on self-report to identify diagnosed diabetes; self-reported diabetes is known to be highly specific (41, 42) , but some misclassification may have occurred. Fourth, despite calibration, small drift in laboratory assays over time is difficult to eliminate. Fifth, fasting glucose measurements were available only in a subsample of each of the surveys, resulting in less precise estimates, particularly in the 2-year survey periods. The 6-year combined estimates are more reliable. Nonetheless, our conclusions about trends were similar across the fasting subsamples and 2-year survey cycles. In addition, the NHANES surveys sampled only noninstitutionalized adults, and therefore, certain segments of the population are not represented in these estimates. For example, diabetes prevalence in nursing homes is unknown, but it is probably high (43) .
In conclusion, the past 2 decades have seen a major increase in the prevalence of diabetes in the U.S. population, from 5.5% to 9.3%, with greater estimates among older adults and minorities; this increase was associated with increases in the prevalence of obesity. In contrast, the prevalence of undiagnosed diabetes remained relatively stable over this period. At present, approximately 89% of all diabetes cases are diagnosed. Furthermore, glycemic control among persons with diagnosed diabetes improved, probably reflecting a combination of improvements in diagnosis, screening, and care. However, a substantial proportion of persons with diabetes still have HbA 1c levels greater than 7.0%, particularly among blacks and Mexican Americans. 
